In the last century cancers have developed into a widespread disease. Seen globally, both the incidence of cancer, as well as – to a smaller extent – the mortality rates […]
Read moreYear: 2014
An updated prostate cancer staging nomogram (Partin tables)
based on cases from 2006 to 2011 John B. Eifler , Zhaoyang Feng , Brian M. Lin , Michael T. Partin , Elizabeth B. Humphreys , Misop Han , Jonathan […]
Read moreContemporary Update of Prostate Cancer Staging Nomograms or the New Millennium
Alan W. Partin, Leslie A. Mangold, Dana M. Lamm, Patrick C. Walsh, Jonathan I. Epstein, and Jay D. Pearson 2001, Urol Jnl Introduction The “Partin tables” were originally developed by […]
Read moreInhibition of Angiogenesis and Promotion of Melanoma Dormancy by Vitamin E Succinate
Annals of Surgical Oncology, 9(10):1023–1032 DOI: 10.1245/ASO.2002.03.580 Mokenge P. Malafa, MD, Frida D. Fokum, PhD, LaKesha Smith, and Audreen Louis Department of Surgery, Southern Illinois University School of Medicine, Springfield, […]
Read moreProstate Cancer Patients Have Lasting Problems
Most Who Had Surgery or Radiation Were Impotent 5 Years Later By Salynn Boyles WebMD Medical News Reviewed By Brunilda Nazario, MD on Tuesday, September 14, 2004 Sept. 14, […]
Read moreAre Needle Biopsies Safe?
By Dr. Ralph Moss from CancerDecisions.com Newsletter A June 2004 report from the John Wayne Cancer Institute in California has rekindled a long-standing debate over whether or not needle […]
Read moreImmunoreactivity of prostate-specific antigen in male breast carcinomas: two examples of a diagnostic pitfall in discriminating a primary breast cancer from metastatic prostate carcinoma.
Diagn Cytopathol 1999 Sep;21(3):167-9 Gupta RK Cytology Unit, Wellington Hospital and School of Medicine, Wellington, and Valley Diagnostic Laboratories, Ltd., Lower Hutt, New Zealand. Prostatic-specific antigen (PSA) is regarded as […]
Read more